Brain-Computer Interfaces (BCI)
- 1st Edition, Volume 229 - April 1, 2027
- Latest edition
- Editor: David B. Teplow
- Language: English
Vitamins and Hormones series, highlights new advances in the field, with this new volume presenting interesting chapters. Each chapter is written by an international board… Read more
End of Summer Sale
Save up to 30% off
Bright savings for research, study, and discovery
Description
Description
Key features
Key features
- Provides the latest information on Brain-Computer Interfaces (BCI) research
- Offers outstanding and original reviews on a range of Brain-Computer Interfaces (BCI) research topics
- Serves as an indispensable reference for researchers and students alike
Readership
Readership
Table of contents
Table of contents
Chattterjee Baibhab
2. Epistemic Injustice in Speech Brain-Computer Interfaces
Veljko Dubljevic
3. Chapter title to come
Miaomiao Yang
4. Chapter title to come
Yu Linwei
5. Chapter title to come
Qian Yun
6. Chapter title to come
Mohamed Baha Ben Ticha
7. Chapter title to come
Rajan Anbarasan
8. Perception and Concerns about Brain Computer Interface
Purvish M. Parikh
9. Chapter title to come
Mitul Kumar Ahirwal
10. Chapter title to come
Thomas Do
11. Chapter title to come
Johannes Kögel
12. Chapter title to come
Ewina Pun
13. Chapter title to come
Kritiprasanna Das
Product details
Product details
- Edition: 1
- Latest edition
- Volume: 229
- Published: April 1, 2027
- Language: English
About the editor
About the editor
DT
David B. Teplow
David B. Teplow, Ph.D., is a Professor of Neurology, Emeritus, at UCLA and an internationally recognized leader in efforts to understand and treat Alzheimer's disease. Dr. Teplow's group has used a multi-disciplinary approach to determine how neurotoxic peptides, such as the amyloid β-protein (Alzheimer's disease) and α-synuclein (Parkinson’s disease), form neurotoxic structures that kill neurons and to develop the means to block these processes. Dr. Teplow received undergraduate training at UC Berkeley; a Ph.D. from the University of Washington; and was a postdoctoral scholar at Caltech. Before coming to UCLA, Dr. Teplow was a faculty member in the Department of Neurology, Harvard Medical School. Dr. Teplow has published >250 peer-reviewed articles, books and book chapters, and commentaries, in addition to serving on numerous national and international scientific advisory boards. Dr. Teplow was a founding editor of the Journal of Molecular Neuroscience and Current Chemical Biology, He is Editor-in-Chief of the Elsevier serial Progress in Molecular Biology and Translational Science and is Associate Editor-in-Chief of the American Journal of Neurodegenerative Disease.